Tentative approval granted to Alembic Pharmaceuticals for pulmonary hypertension treatment by FDA
Alembic Pharmaceuticals Limited has achieved a significant milestone by securing tentative approval from the US Food & Drug Administration (USFDA) for its Selexipag for Injection, ... Read More
Fresenius Kabi launches generic Arsenic Trioxide Injection in US to enhance oncology treatment options
German health care company Fresenius Kabi has announced the US launch of its new generic drug, Arsenic Trioxide Injection. This product, a generic version of ... Read More
Pfizer exits Chinese generic drugs JV, Hisun-Pfizer Pharmaceuticals
In a significant shift within the pharmaceutical industry, Pfizer Inc. has announced its decision to exit the Hisun-Pfizer Pharmaceuticals joint venture by divesting its 49% ... Read More
Mylan launches generic hypertension drugs Benicar and Benicar HCT in US
Global pharmaceutical giant Mylan has made a significant stride in the hypertension treatment market with the US launch of the first generic versions of Daiichi ... Read More